|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
MAY INCREASE DROWSINESS EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
INCREASED SEDATIVE EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
MAY INCREASE DROWSINESS EFFECT
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
SEDATIVE EFFECT IS POTENTIATED
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
MAY INCREASE DROWSINESS EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
ANTIHISTAMINES MAY DECREASE THE HAEMOSTATIC ACTION
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
INCREASED SEDATIVE EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
ATROPINE LIKE ANTICHOLENERGIC SIDE EFFECTS MAY POTENTIATE LEADING TO CENTRAL ANTICHILENERGIC SYNDROME
|
MAY INCREASE DROWSINESS EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CONCURRENT USE WITH H-1 RECEPTOR BLOCKER LIKE ASTEMIZOLE, ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
CO-ADMINISTRATION CAN ENHANCE THE ANTIMUSCARINIC EFFECTS OF THE DRUG LIKE DRYNESS OF MOUTH, PALPITATION ETC
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|